Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research Report), ...
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
AIDS experts doubt UNAIDS claim of a cure by 2030
Local AIDS experts are at odds with the United Nations Programme on HIV/AIDS (UNAIDS) over its claims that AIDS could be cured by 2030 if pharmaceutical companies allow much more effective new drugs ...
Why Gilead Sciences (GILD) Is One of the Best Humane Stocks to Invest in Now?
We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...
GILD vs. ALNY: Which Stock Is the Better Value Option?
Based on these metrics and many more, GILD holds a Value grade of A, while ALNY has a Value grade of D. Both GILD and ALNY are impressive stocks with solid earnings outlooks, but based on these ...
7 Best Pharmaceutical Stocks to Buy for Income
The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year.
Vertex Pharmaceuticals (VRTX) Receives a Hold from RBC Capital
In a report released on January 21, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research ...
Bay Area Reporter6dOpinion
Guest Opinion: Betrayed by our advocates
Mark S. King’s January 10 blog post on his award-winning "My Fabulous Disease" site made me aware of a new, and troubling, ...
BioSpace6d
Almost 5 Years into $5B Galapagos Partnership, Gilead Execs Start Over With New Spinoff
Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at ...